CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer.

MLA

Liu, Shini, et al. “CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer.” Advanced Science, vol. 11, no. 45, Dec. 2024, pp. 1–17. EBSCOhost, https://doi.org/10.1002/advs.202403782.

APA

Liu, S., Deng, P., Yu, Z., Hong, J. H., Gao, J., Huang, Y., Xiao, R., Yin, J., Zeng, X., Sun, Y., Wang, P., Geng, R., Chan, J. Y., Guan, P., Yu, Q., Teh, B., Jiang, Q., Xia, X., Xiong, Y., & Chen, J. (2024). CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer. Advanced Science, 11(45), 1–17. https://doi.org/10.1002/advs.202403782

Chicago

Liu, Shini, Peng Deng, Zhaoliang Yu, Jing Han Hong, Jiuping Gao, Yulin Huang, Rong Xiao, et al. 2024. “CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer.” Advanced Science 11 (45): 1–17. doi:10.1002/advs.202403782.